Search for: "ELI LILLY AND COMPANY"
Results 1 - 20 of 361
Sorted by Relevance | Sort by Date
RSS Subscribe:  20 results  |  100 results
29 Apr 12:44 pm
... the right decision. Many of the lawsuits filed against Eli Lilly and Co. contend the company has misled patients and physicians about Zyprexa's potential side effects. These side effects include diabetes, hyperglycemia and excessive weight gain. The company has denied any wrongdoing in these civil cases. Apparently, ... state taxpayers. "The attorney general's office looked at the anticipated Medicaid losses and calculated the payout would be about double what Georgia's claims would have been.," ...
Atlanta Personal Injury Law Blog - http://atlanta.injuryboard.com/
5 Mar, 2007 8:29 pm by Donald Zuhn
By Mark Chael Eli Lilly and Co. (NYSE: LLY) announced today that it will acquire Hypnion, Inc. of Lexington, MA., a privately held CNS drug discovery company investigating sleep and wakefulness-alertness disorders as well as circadian rhythm abnormalities. Financial terms of the deal, which is expected to close in 2007,...
Patent Docs - http://patentdocs.typepad.com/patent_docs/
20 Dec, 2006 10:00 am
... from doctors about Zyprexa's links to obesity and its tendency to raise blood sugar - both known risk factors for diabetes. (link) To the Editor: "Eli Lilly Said to Play Down Risk of Top Pill" (front page, Dec. 17), about the company's decision to cover up health effects of ... to sign confidentiality agreements, as was apparently done in this case. In such cases, wrongdoers can prolong misconduct and suppress information for years. If lawsuits had not been brought in this case and a ...
TortDeform - http://www.tortdeform.com/
16 Oct, 2008 9:05 pm by Michael A. DeMayo
... antipsychotic drug. This record settlement comes a few months after North Carolina and other states reached a $58 million settlement with Merck over allegations that the drugmaker ... physicians can prescribe drugs to patients for uses that are not FDA-approved, drug companies are not allowed to market medications for off-label purposes. Dangerous Drug Litigation ... ad claims, The Bismark Tribune, May 21, 2008 Related Web Resources: Eli Lilly and Company Zyprexa North Carolina Attorney General Roy Cooper ...
North Carolina Injury Lawyer Blog - http://www.northcarolinainjurylawyerblog.com/
15 Jan 7:24 pm
Pharmaceutical giant, Eli Lilly and Company, plead guilty to promoting its drug Zyprexa for "off-label" uses. The plea resulted in the company paying $515 million in criminal fines. This is the largest payment made from an individual corporate criminal fine in history. In addition to the large payout, Eli Lilly signed a civil settlement admitting that by marketing the drug for unapproved use, it caused false claims for payment and negatively affected ...
Quitam Help - http://www.quitamhelp.com/
20 Jan 3:39 am by Qui Tam
Eli Lilly and Company has agreed to plead guilty and pay $1.415 billion for promoting its drug Zyprexa for uses not approved by the Food and ... were brought under the qui tam provisions of the False Claims Act, alleging that Lilly marketed its antipsychotic drug Zyprexa for uses that had not been approved by the FDA ... false claims for payment to be submitted to federal insurance programs such as Medicaid, TRICARE and the Federal Employee Health Benefits Program, none of which provided coverage for such ...
False Claims Act/Qui Tam - http://quitam.blogspot.com/
24 Feb 9:43 pm by Patent Docs
... 30-month stay under 21 U.S.C. § 355(j)(5)(B)(iii), thereby preventing the U.S. Food and Drug Administration from approving the Abbreviated New Drug Application (ANDA) filed by Defendant-Appellant Teva Pharmaceuticals USA, Inc. Seeking approval to manufacture and market a generic version of Plaintiff-Appellee Eli Lilly and Company's raloxifene hydrochloride formulation, which Lilly markets as Evista® for the treatment and prevention of ...
Patent Docs - http://patentdocs.typepad.com/patent_docs/
3 Mar, 2008 9:12 pm by Beck/Herrmann
... we really liked what a federal trial court did in Ebel v. Eli Lilly and Company, No. B-04-194, slip op. (S.D. ... decedent's death. Plaintiff pleaded the typical strict liability, negligence, misrepresentation, and breach of warranty claims. Our only quibble with the trial court is in its discussion of the burden ... .007(a). Her evidence of overpromotion, however, was inadmissible: an article from The New York Times and a document pulled from a website. Slip op. at 9. Even if admissible, the internal ...
Drug and Device Law - http://druganddevicelaw.blogspot.com
30 Jan 3:27 am
... effective drug for treating ADHD. Leading up to approval and as part of the FDA approval process, Eli Lilly (Lilly) conducted six placebo-controlled clinical studies ... harmful effects from taking Strattera. As a result, only one participant completed the study and there were four additional enrollees who "had still not fallen off," ... existing drugs so far that people have begun to notice. The FDA slapped the company's wrists for its marketing of Strattera, saying it had falsely broadened the drug's ...
West Palm Beach Personal Injury Lawyer - http://westpalmbeach.injuryboard.com/
30 Jan, 2008 8:22 am by Ashby Jones
... lawyer for big pharma. Busy busy busy times. The latest: Eli Lilly and federal prosecutors are discussing a settlement of a civil and criminal investigation into the company’s marketing of Zyprexa, an antipsychotic drug. The settlement could end ... crossed our radar screen early last year, when Judge Jack Weinstein castigated a plaintiffs' expert, an Alaska lawyer and a New York Times reporter for attempting to circumvent a protective order concerning internal Lilly documents. Those documents led ...
Tags: Care, Health
Law Blog - http://blogs.wsj.com/law
10 Jun, 2005 4:52 pm by David Austin
The New York Times reported today that Eli Lilly & Company has agreed to settle thousands of lawsuits based upon the medication, Zyprexa, used to treat schizophrenia and bipolar disorder. The times reports that Zyprexa is Eli Lilly's ... but it appears that this is a settlement that has been worked out between the Plaintiff's Management Committee and the Eli Lilly. Some articles are suggesting that it might have some sort of opt out "option" similar to the fen-phen settlement. ...
Prescription Drug Liability Law Blog - http://www.prescription-drug-liability-law-blog.com/
8 Sep, 2008 1:40 pm by Marcia Oddi
... certified a class of "third-party payors," such as pension funds, labor unions and insurance companies, in their claim that the drug giant Eli Lilly committed fraud by overpricing its anti-psychotic drug Zyprexa while overstating the drug's ... and onto the Internet. In his 2007 decision, Weinstein enjoined a number of the individual conspirators from further disseminating the documents and ordered them to return any in their possession. Weinstein has now ordered the seal removed, though he referred ...
The Indiana Law Blog - http://indianalawblog.com/
14 Feb, 2007 5:27 am by Marcia Oddi
... (ED NY) ruled yesterday that confidential marketing materials belonging to Eli Lilly & Company about its top-selling anti-psychotic drug Zyprexa must be returned to the company by a doctor and a lawyer who, the judge said, engaged in a scheme to ... old-school) to a story today in the NY Times. More from the story: The documents were part of evidence provided by Lilly as part of a lawsuit filed by patients who claimed that side effects from Zyprexa caused excessive weight gain and diabetes. In ...
The Indiana Law Blog - http://indianalawblog.com/
23 Mar, 2007 3:21 pm by Marcia Oddi
The ILB has had a number of entries (see list here) on Lilly's drug Zyprexa. Most recently was this entry from Feb. 14th, 2007 on the 78-page ED NY ... marketing materials belonging to Eli Lilly & Company about its top-selling anti-psychotic drug Zyprexa must be returned to the company by a doctor and a lawyer who, the judge said, ... York Times Reporter's First Amendment Civil Disobedience Claim: The Case of the Secret Eli Lilly Zyprexa Documents," which begins: Last month, Judge Jack Weinstein of ...
The Indiana Law Blog - http://indianalawblog.com/
30 Jan 6:08 pm
... over the years about litigation concerning the drug. Billions in fines and settlements paid by the drug's maker Eli Lilly, and fights with The New York Times over leaked discovery documents, ... pattern with those drugs where something's gone wrong. For four or five years the company will fight tooth-and-nail with any scientists who say that they've cooked the books. They'll be very antagonistic to reporters who ask questions and then, around year 10 you start seeing a lot more accommodations. They ...
LawBeat - http://newhouse-web.syr.edu/legal/blog.cfm
9 Nov, 2006 8:22 am by Marcia Oddi
... TERRE HAUTE - About 175 people have come forward to share their stories to fuel the race discrimination lawsuit against Eli Lilly and Co., said one of the plaintiffs in the case, Cassandra Welch, at a public information session Wednesday night. * * * The federal lawsuit, filed April 21, alleges that black employees of Lilly have been victims of unlawful discrimination and that the company paid black employees less than their white counterparts. It also alleges black employees ...
The Indiana Law Blog - http://indianalawblog.com/
24 Oct, 2008 1:09 pm by Ed Wallis
As reported by the Indianapolis Star, Eli Lilly and Co. announced Tuesday that it is prepared to pay more than $1.4 billion to settle state and federal investigations related to the drugmaker's marketing of the antipsychotic medication Zyprexa. In a statement, the company said it believes it is now in compliance with all marketing regulations. Earlier this month, Lilly agreed to pay $62 million to resolve claims over Zyprexa marketing with 32 states. ...
Mid South Trial Lawyer - http://www.midsouthtriallawyer.com
7 Oct, 2008 4:01 pm by admin
NEW YORK (AP) _ Eli Lilly & Co. said Tuesday it will pay $62 million to resolve investigations into the marketing and promotion of its antipsychotic drug Zyprexa ... take a related charge of 4 cents per share in the third quarter. Zyprexa, the company's top-selling drug with 2007 sales of $4.8 billion, will continue to ... has not been FDA-approved to treat. A federal judge in July recommended that Lilly settle that case. The states involved in Tuesday's settlement are Alabama, Arizona, California, ...
LawInfo Weblog - http://blog.lawinfo.com
9 Jun 11:39 am by Heather Young
... Court for the Southern District of Indiana, Indianapolis Division, on behalf of a nationwide group of current and former employees of Eli Lilly Company. At the same time, the plaintiffs filed an amended complaint alleging that the pharmaceutical giant ... practices deny these African Americans an equal opportunity to advance in their careers. Accompanying the class certification motion and amended complaint were certified declarations by more than 100 members of the class throughout the United States ...
Legal Radar - http://www.legalradar.com/
16 Jan 12:30 pm
... were urged to promote use of Zyprexa for use in dementia patients. Documents produced in court have shown that the company greedily pushed Zyprexa to treat a variety of disorders that it was never approved for, including aggression, dementia and dementia ... the previous one. Eli Lilly's greed for profits at the cost of the health of thousands of patients isn't the first instance of corporate greed by a pharmaceutical company, but it was astonishing in how widespread and audacious the unscrupulous ...
Georgia Injury Law Blog - http://www.georgiainjurylawblog.com/
        Next >
Add to your RSS Reader Add to your Google Add to your My Yahoo Add to your My MSN Add to your My AOL Add to your Feedster Add to your Newsgator Add to your Bloglines Add to your NewsBurst Add to your Rojo Add to your Pluck